Aptevo Therapeutics (APVO) Balance Sheet: Assets & Liabilities

Aptevo Therapeutics (APVO) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Aptevo Therapeutics reported total assets of $27.19M and total liabilities of $9.81M. Shareholders' equity was $17.38M, up 265.5% from $4.75M a year earlier. Total debt stood at $4.63M against $21.62M in cash and short-term investments, a net cash position of $16.99M. That puts debt-to-equity at 0.27, compared with 0.97 a year earlier.

Aptevo Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Aptevo Therapeutics Inc. (APVO) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Mar 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	21.62	8.71	16.90	22.64	45.04	39.98	39.98	12.45	30.64	7.10
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	73.69
Cash & Short-Term Investments	21.62	8.71	16.90	22.64	45.04	39.98	39.98	12.45	30.64	80.78
Accounts Receivable	0.00	0.00	0.00	2.50	3.66	2.37	2.37	7.02	5.22	2.14
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	-	6.14	1.79	1.03
Other Current Assets	1.46	1.95	0.69	2.32	3.86	4.92	2.23	4.39	11.05	11.13
Total Current Assets	23.08	10.66	19.07	27.45	52.57	47.26	47.26	30.00	48.69	95.08
Non-Current Assets
Property, Plant & Equipment (Net)	4.11	4.93	5.78	6.77	3.96	5.54	5.54	7.69	5.20	5.84
Long-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	7.45	-17.37
Intangible Assets	0.00	0.00	0.00	0.00	0.00	0.00	-	4.42	5.25	6.08
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.07	0.75	0.75	11.30	8.35	10.00
Total Non-Current Assets	4.11	4.93	5.78	6.77	4.03	6.28	-	23.41	18.81	21.92
Total Assets	27.19	15.59	24.84	34.22	56.60	53.55	53.55	53.41	67.49	117.01
Current Liabilities
Accounts Payable	0.88	3.05	0.00	3.50	0.00	0.00	5.58	13.04	11.67	7.35
Short-Term Debt	0.87	0.00	0.00	2.00	11.67	5.00	5.00	19.86	0.00	3.33
Current Portion of Long-Term Debt	-	-	-	2.00	11.67	-	5.00	-	-	-
Accrued Liabilities	4.31	4.20	2.10	2.11	2.08	-	2.76	-	-	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	-7.35
Other Current Liabilities	4.31	3.15	1.14	1.10	23.09	9.54	1.20	5.33	5.94	7.83
Total Current Liabilities	6.05	6.21	7.22	8.71	34.76	14.54	14.54	38.24	17.61	18.51
Non-Current Liabilities
Long-Term Debt	3.76	4.63	5.40	1.46	5.05	22.41	20.05	3.33	19.28	15.73
Deferred Tax Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	-0.22
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	15.58	0.00	-	0.00	0.20	0.73
Total Non-Current Liabilities	3.76	4.63	5.40	7.54	20.63	22.41	-	3.33	19.48	16.46
Total Liabilities	9.81	10.84	12.62	16.24	55.39	36.95	36.95	41.57	37.09	34.97
Stockholders' Equity
Common Stock	0.11	0.08	0.06	0.05	0.05	0.05	0.05	0.05	0.02	0.02
Retained Earnings	-275.12	-247.58	-223.45	-206.04	-214.06	-185.61	-185.61	-167.86	-127.41	-73.72
Accumulated Other Comprehensive Income	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	-0.11
Additional Paid-in Capital	292.38	252.25	235.61	223.96	215.23	202.15	-	179.65	157.79	155.84
Shares Outstanding	1.00	0.00	0.00	0.00	0.00	-	-	-	-	-
Total Stockholders' Equity	17.38	4.76	12.22	17.97	1.22	16.59	16.59	11.84	30.41	82.04
Total Liabilities & Equity	27.19	15.59	24.84	34.22	56.60	53.55	-	53.41	67.49	117.01

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Aptevo Therapeutics Balance Sheet

How much debt does Aptevo Therapeutics have?

Aptevo Therapeutics had total debt of $4.63M as of Dec 31, 2025, against $21.62M in cash and short-term investments. Its debt-to-equity ratio was 0.27. Total debt was $4.63M a year earlier.

What are Aptevo Therapeutics's total assets?

Aptevo Therapeutics reported total assets of $27.19M as of Dec 31, 2025, up 74.4% from $15.59M a year earlier. Total liabilities were $9.81M.

What is Aptevo Therapeutics's shareholders' equity?

Aptevo Therapeutics's shareholders' equity was $17.38M as of Dec 31, 2025, or about $17.42 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition